Renal and cardiovascular effects of irbesartan in dialysis patients--a randomized controlled trial protocol (SAFIR study)

Danish medical journal

Volumn 60, Issue 4, 2013, Pages A4602-

  Peters, Christian D augaard ^a   Kjærgaard, Krista D ybtved ^a   Jespersen, Bente ^a   Christensen, Kent L odberg ^a   Jensen, Jens D am ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BIPHENYL DERIVATIVE; IRBESARTAN; TETRAZOLE DERIVATIVE;

ARTERIAL STIFFNESS; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; ECHOGRAPHY; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FUNCTION TEST; METHODOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BIPHENYL COMPOUNDS; DOUBLE-BLIND METHOD; HEMODYNAMICS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FUNCTION TESTS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RESEARCH DESIGN; TETRAZOLES; VASCULAR STIFFNESS;

EID: 84892534688     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (0)